Related Experiment Video

Updated: May 10, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

The new kid on the block: RET in lung cancer

Justin F Gainor1, Alice T Shaw

  • 1Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.

Cancer Discovery
|June 11, 2013
PubMed

Insights

RET fusions are key drivers in some non-small cell lung cancers (NSCLC). A new RET inhibitor shows promise, validating RET as a crucial therapeutic target for NSCLC patients with these fusions.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The RET proto-oncogene plays a role in various cancers.
  • RET fusions have been identified as oncogenic drivers in a subset of non-small cell lung cancer (NSCLC) patients.
  • Targeting specific genetic alterations is a key strategy in modern cancer therapy.

Purpose of the Study:

  • To evaluate the efficacy of a novel RET inhibitor in patients with RET fusion-positive NSCLC.
  • To validate RET as a druggable target in the context of lung cancer.
  • To present preliminary clinical trial data on a new targeted therapy.

Main Methods:

  • A clinical trial was conducted involving patients with RET fusion-positive NSCLC.
  • Patients received treatment with a specific RET inhibitor.
  • Tumor samples were analyzed for RET alterations.

Main Results:

  • Preliminary data indicate that the RET inhibitor demonstrated activity in patients with RET fusion-positive NSCLC.
  • The study validates RET as a viable therapeutic target.
  • Further clinical investigation is warranted.

Conclusions:

  • RET inhibitors represent a promising therapeutic strategy for a subset of NSCLC patients.
  • Targeting RET fusions can lead to clinical benefit in lung cancer.
  • This research supports the development of precision medicine approaches in NSCLC.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...